Navigation Links
Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics
Date:7/30/2008

As 600,000 visitors and athletes gear up to travel to China for the 2008 Olympic Games, travelers should be most concerned about respiratory illnesses and dog bites, according to report by an Emory University travelers' health expert, her colleagues at the Centers for Disease Control and Prevention (CDC) and around the globe.

Dog bites in humans can lead to human rabies. The report finds that respiratory illnesses and dog bites are more common than contracting exotic diseases. Other common ailments seen while traveling in China were diarrhea, sprains and strains, and skin conditions such as eczema and insect stings.

The report, published in the July issue of the American Journal of Tropical Medicine and Hygiene, gives vital information to help travelers plan their trips to the 2008 Olympics in Beijing next month. It also assists travel medicine experts and clinics around the world to better advise their patients about prevention during pre-travel visits and consultations.

"People tend to let their guard down and not use common sense while traveling, many times not considering they may be putting their health at risk," says Phyllis Kozarsky, MD, professor of medicine (infectious diseases) at Emory University School of Medicine, and medical director of TravelWell, a pre- and post-travel clinic based at Emory Crawford Long Hospital. "We advise travelers in our clinic to enjoy themselves while on vacation, but don't throw caution to the wind."

The report analyzed health outcomes associated with travel over the past 10 years to China and two other regions of Asia Southeast Asia and India. The data were collected by more than 40 tropical medicine clinics worldwide, all part of the GeoSentinel Surveillance Network. The surveillance network, founded by the International Society of Travel Medicine and supported by the CDC, records health trends associated with travel to foreign destinations. TravelWell is one of the clinics
'/>"/>

Contact: Janet Christenbury
jmchris@emory.edu
404-727-8599
Emory University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
4. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
5. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
6. Fire Season: Respiratory Health a Concern
7. Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities
8. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
9. Recently discovered virus associated with pediatric respiratory tract infection in Germany
10. New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD
11. Kids Respiratory Virus Season Off and Running

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ndall Hunt authors earned the 2009 Gifted Child Qu...onal Association for Gifted Children’s annua... Dubuque, IA (PRWEB) Decemb...d the 2009 Gifted Child Quarterly Paper of the Yea...ted Children’s annual conference in St. Loui...
(Date:12/2/2009)...re/ -- In response to rising suicide and divorce r...rofit ministry dedicated to supporting marriages a...® marriage conference at a significant disco...13 at the Grand Hyatt Atlanta in Buckhead (3300 Pe...iage getaway aimed at strengthening healthy marria...
(Date:12/2/2009)...paign Features Small Business Owners Detailing How... Jobs ,, WASHINGTON, Dec. 2 /PRNewswire-USNews...led for Thursday, Keeping Small Business Healthy, ...unced a new $1 million 4 state TV ad campaign targ...h care legislation on small business owners and ho...
(Date:12/2/2009)...RNewswire-USNewswire/ -- At a recently concluded f...delegates came together to outline the future of m...he necessary thrust. Organized by the Medical Tour...tion.com , the high-powered congregation of senior...nities and requests for assistance in medical tour...
(Date:12/2/2009)..., Dec. 2 Lockton Benefit Group i...cal view on proposed health reform legislation wor...newscom.com/cgi-bin/prnh/20090415/CG99351LOGO ) ,... the legislation, according to Ed Fensholt and Mar...Compliance Services Division and Lockton,s Healt...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2
...aid that older hospital patients with delirium run...e condition. Researchers suggested there's a need ...nt can be made and to investigate interventions th...onal delirium - described as possible hallucinatio...
... may be only a dash and sprinkel away: Researchers...d that herbs, in addition to making food tastier, ...rovide potential anticancer benefits when suppleme...dings appear in the Journal of Agricultural and Fo...
...a recent study a device was found using new techno... of screening people for potential stroke involves...arotid arteries that serve the brain.// Resear...e, this was used to take two different images in a...
...hat protects children against measles, mumps and r... growing list of scarce drugs, with shortfalls cau... pharmaceutical companies choosing to stop making ...neumococcal vaccine used to prevent bacterial meni...
...s are confirming in laboratory studies that one of...ted from beehives--may inhibit the development of ...inas, Brazil, found that propolis// considerably r...promote the binding of cariogenic bacteria to teet...
...now say that a region in the brain responsible for...pathise for others and help the needy. Neuroscient... brain regions involved in learning by imitation./...inguish the self from others.The research, done by...
Other Medicine News:Health News:Herbs: rich soure of antioxidants 2Health News:The brain wave 2
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewsw...e" or the "Company") (NYSE: SCR ), a leading pha...t, manufacturing, and marketing of branded,generic...eported that its,subsidiary Jiangsu Yanshen Biolog...) has suspended production of all its products in ...
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PRN..., including a late-breaking presentation on Tasign...hronic myeloid leukemia, demonstrate the strength ... the care of patients. ,, The new data, at the...Meeting and Exposition, highlight the company,s cu...
(Date:12/1/2009)..., , TEMECULA, Calif., Dec. 1 /PRNewswire-Fi... Bulletin Board: PSTX) announced today that it has...of Chief Financial Officer, Treasurer and Corporat...cting CFO since 2008. Prior to joining Patient Sa...nt Finance, Chief Financial Officer, Treasurer and...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Humans Can Develop Bat Like Echolocation 51093 1Humans Can Develop Bat Like Echolocation 51093 2Communicating science to decision makers 51089 1Omega 3s Benefit Heart Attack Survivors Healthy Adults Mothers and Infants 51086 1Omega 3s Benefit Heart Attack Survivors Healthy Adults Mothers and Infants 51086 2
...SS WIRE)--Jun 5, 2007 - Javelin,Pharmaceuticals, I...ucts for pain control, today announced that its Ph...n Pain Medicine, the,official journal of The Ameri...d, "Analgesic Efficacy and Safety of,Morphine-Chit...evere Pain Following Orthopedic Surgery", was rece...
...ta Presented at the , 2007 American Society of Cli...) Activity in Older Patients with AML and in,Refra...on of the molecular interaction of Aloxi(R),with ,...rvival Analysis of Glioblastoma Patients,Treated ,...cribed-- , --Survival Analysis of Irofulven in Sec...
Other Medicine Technology:Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine),Data Published in Pain Medicine 2Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine),Data Published in Pain Medicine 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10
Right Dr. White Carina Hook
SHERIDAN LASER-TRACH Endotracheal Tubes
SHERIDAN LAR-A-JECT® Reinforced Laryngectomy Tubes
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes
Medicine Products: